Search results
First Solar shares gain as Goldman Sachs raises target, keeps Buy rating By Investing.com
Investing.com· 6 days agoOn Monday, Goldman Sachs (NYSE:GS) updated its outlook on First Solar (NASDAQ:FSLR), increasing the...
NVIDIA stock retains Conviction Buy rating from Goldman By Investing.com
Investing.com· 6 days agoOn Monday, Goldman Sachs (NYSE:GS) maintained its Conviction Buy rating and a $1,200.00 price target...
Looking At Goldman Sachs Gr's Recent Unusual Options Activity - Goldman Sachs Gr (NYSE:GS)
Benzinga· 3 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Goldman Sachs Gr. Our analysis of options history for Goldman< ...
ZEEKR Intelligent Technology (NYSE:ZK) Research Coverage Started at The Goldman Sachs Group
ETF DAILY NEWS· 5 days agoStock analysts at The Goldman Sachs Group started coverage on shares of ZEEKR Intelligent Technology...
Is Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) a Strong ETF Right Now?
Zacks· 2 days agoSmall Cap Blend category of the market, the Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC Quick QuoteGSSC - Free Report) is a smart beta exchange ...
Goldman Sachs Has Potential For Alpha Generation: Analyst - Goldman Sachs Gr (NYSE:GS)
Benzinga· 6 days agoGoldman Sachs has a Buy rating and price target of $525; Shares declined by 0.9% to $452.47 at last...
Ex-Goldman Sachs banker wins part of appeal, still faces extradition to US
Reuters· 2 days agoBerko was charged with six offences in New York in 2020 relating to his time working for Goldman Sachs. Berko's lawyers said he could not be extradited ...
Goldman Sachs added these 2 stocks to its conviction list in June By Investing.com
Investing.com· 6 days agoGoldman Sachs announced the June update for its "European Conviction List - Directors’ Cut" report...
Ex-Goldman Sachs Banker Wins Part of Appeal, Still Faces Extradition to US
US News & World Report· 2 days agoFormer Goldman Sachs banker Asante Berko who is wanted in the United States for allegedly paying bribes to Ghanaian officials on Friday won part of his ...
Goldman Sachs says buy this biotech stock with more than 60% upside
CNBC· 4 days agoIt's time for investors to buy the dip on Jazz Pharmaceuticals , according to Goldman Sachs. The...